0 CHECKOUT

PRODUCT FILTERS

REGION

821
430
430
383
383

COUNTRY

374
56
48
39
39

PRICE

200
634
1,099
2,076

PUBLISHED

174
578
988
2,076

PRODUCT TYPE

1,624
328
79
36
8
1

Central Nervous System Drugs

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Global and Chinese Doxylamine succinate (CAS 562-10-7) Industry - 2016

The 'Global and Chinese Doxylamine succinate Industry, - 2016' is a professional and in-depth study on the current state of the global Doxylamine succinate industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese Tasimelteon (CAS 609799-22-6) Industry - 2016

The 'Global and Chinese Tasimelteon Industry - 2016' is a professional and in-depth study on the current state of the global Tasimelteon industry with a focus on the Chinese market. The report provides...

Published:  April 2016
Price:  From

Global and Chinese Masitinib Industry - 2016

The 'Global and Chinese Masitinib Industry - 2016' is a professional and in-depth study on the current state of the global Masitinib industry with a focus on the Chinese market. The report provides...

Published:  April 2016
Price:  From

Global and Chinese Acetylleucine (CAS 99-15-0) Industry - 2016

The 'Global and Chinese Acetylleucine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Acetylleucine industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Boc-D-Allylglycine (CAS 170899-08-8) Industry - 2016

The 'Global and Chinese Boc-D-Allylglycine Industry, - 2016' is a professional and in-depth study on the current state of the global Boc-D-Allylglycine industry with a focus on the Chinese market. The...

Published:  April 2016
Price:  From

Global and Chinese Azacyclonol (CAS 115-46-8) Industry - 2016

The 'Global and Chinese Azacyclonol Industry - 2016' is a professional and in-depth study on the current state of the global Azacyclonol industry with a focus on the Chinese market. The report provides...

Published:  April 2016
Price:  From

Global and Chinese Benactyzine (CAS 302-40-9) Industry - 2016

The 'Global and Chinese Benactyzine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Benactyzine industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese Benactyzine Hydrochloride Industry - 2016

The 'Global and Chinese Benactyzine Hydrochloride Industry, - 2016' is a professional and in-depth study on the current state of the global Benactyzine Hydrochloride industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Butyrophenone (CAS 495-40-9) Industry - 2016

The 'Global and Chinese Butyrophenone Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Butyrophenone industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese (S)-N-Boc-allylglycine (CAS 90600-20-7) Industry - 2016

The 'Global and Chinese (S)-N-Boc-allylglycine Industry, - 2016' is a professional and in-depth study on the current state of the global (S)-N-Boc-allylglycine industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese D-Allylglycine (CAS 54594-06-8) Industry - 2016

The 'Global and Chinese D-Allylglycine Industry, - 2016' is a professional and in-depth study on the current state of the global D-Allylglycine industry with a focus on the Chinese market. The report...

Published:  April 2016
Price:  From

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Huntington's Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual...

Published:  March 2015
Price:  From

Global Multiple Sclerosis Drugs Market 2014-2018

About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath...

Published:  August 2014
Price:  From

Global Huntington's Disease Therapeutics Market 2014-2018

About Huntington's Disease Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically...

Published:  October 2014
Price:  From

Inhaled CNS Therapeutics

Neurological disorders are highly prevalent worldwide And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden...

Published:  June 2014
Price:  From

Neurology Drug Report 2014

This report for the first time identifies and profiles 480 Active Neurology focused Drug Development companies from 31 countries worldwide, developing 801 neurological disorders targeting drugs It evaluates...

Published:  May 2014
Price:  From

US CNS Disorders Drug Pipeline Insight 2014

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available...

Published:  August 2014
Price:  From

Global Alzheimer's Drugs Market 2014-2018

Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65...

Published:  June 2014
Price:  From

Perampanel - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent,...

Published:  May 2016
Price: 
Loading Indicator

Our Clients